Detalles de la búsqueda
1.
Talazoparib versus chemotherapy in patients with germline BRCA1/2-mutated HER2-negative advanced breast cancer: final overall survival results from the EMBRACA trial.
Ann Oncol;
31(11): 1526-1535, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32828825
2.
Quality of life with talazoparib versus physician's choice of chemotherapy in patients with advanced breast cancer and germline BRCA1/2 mutation: patient-reported outcomes from the EMBRACA phase III trial.
Ann Oncol;
29(9): 1939-1947, 2018 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30124753
3.
Statistical controversies in clinical research: statistical significance-too much of a good thing .
Ann Oncol;
27(5): 760-2, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26861602
4.
Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial.
Ann Oncol;
27(6): 1041-1047, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26940688
5.
Higher rate of severe toxicities in obese patients receiving dose-dense (dd) chemotherapy according to unadjusted body surface area: results of the prospectively randomized GAIN study.
Ann Oncol;
27(11): 2053-2059, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27502721
6.
Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12.
Ann Oncol;
26(2): 313-20, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25403582
7.
The 21-gene recurrence score assay impacts adjuvant therapy recommendations for ER-positive, node-negative and node-positive early breast cancer resulting in a risk-adapted change in chemotherapy use.
Ann Oncol;
24(3): 618-24, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23136233
8.
Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial.
Ann Oncol;
24(11): 2786-93, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23970015
9.
Locoregional treatments for triple-negative breast cancer.
Ann Oncol;
23 Suppl 6: vi30-4, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23012299
10.
Phase IB study of the EpCAM antibody adecatumumab combined with docetaxel in patients with EpCAM-positive relapsed or refractory advanced-stage breast cancer.
Ann Oncol;
23(9): 2306-2313, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22357251
11.
Oblimersen combined with docetaxel, adriamycin and cyclophosphamide as neo-adjuvant systemic treatment in primary breast cancer: final results of a multicentric phase I study.
Ann Oncol;
19(10): 1698-705, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-18477581
12.
Pegfilgrastim +/- ciprofloxacin for primary prophylaxis with TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy for breast cancer. Results from the GEPARTRIO study.
Ann Oncol;
19(2): 292-8, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-17846019
13.
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006.
Ann Oncol;
18(12): 1927-34, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17998286
14.
Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group.
J Clin Oncol;
14(7): 2000-11, 1996 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-8683230
15.
Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial Group.
J Clin Oncol;
7(8): 1113-9, 1989 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-2526863
16.
Maximized reduction of primary breast tumor size using preoperative chemotherapy with doxorubicin and docetaxel.
J Clin Oncol;
17(7): 1999-2005, 1999 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-10561250
17.
Dose-dense doxorubicin, docetaxel, and granulocyte colony-stimulating factor support with or without tamoxifen as preoperative therapy in patients with operable carcinoma of the breast: a randomized, controlled, open phase IIb study.
J Clin Oncol;
19(15): 3506-15, 2001 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-11481357
18.
Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study.
J Clin Oncol;
20(24): 4628-35, 2002 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12488406
19.
A randomised study to compare the effect of the luteinising hormone releasing hormone (LHRH) analogue goserelin with or without tamoxifen in pre- and perimenopausal patients with advanced breast cancer.
Eur J Cancer;
31A(2): 137-42, 1995.
Artículo
en Inglés
| MEDLINE | ID: mdl-7718316
20.
A randomised trial comparing two doses of the new selective aromatase inhibitor anastrozole (Arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancer.
Eur J Cancer;
32A(3): 404-12, 1996 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-8814682